Literature DB >> 35859872

Thermal Degradation Kinetics and pH-Rate Profile of Verbascoside and Stability Improvement by Solid Lipid Nanoparticles.

Vanuchawan Wisuitiprot1, Kornkanok Ingkaninan2, Panlop Chakkavittumrong3, Wudtichai Wisuitiprot4, Eakkaluk Wongwad2,5, Neti Waranuch1,6.   

Abstract

Thermal degradation of verbascoside (VB) in Acanthus ebracteatus Vahl (AE) always affects its health benefit. Here the temperature effect on VB in both AE extract and solid lipid nanoparticles (SLNs)-encapsulated AE extract was demonstrated using the Arrhenius plot. The reaction rate constants were calculated for shelf life and plotted to obtain pH-rate profiles. VB degradation was a first-order reaction. The reaction rate in a neutral to alkaline solution was faster than in an acidic solution. VB in AE extract-loaded SLNs was more stable than in uncapped AE extract. The shelf life of VB in SLNs was 153 days with activation energy (E a) of 76.16 kJ mol-1, whereas those of VB in AE extract and in AE extract solution were 75 days with E a = 78.03 kJ mol-1 and 12 days with E a = 49.24 kJ mol-1, respectively. Therefore, we anticipate that the AE extract-loaded SLNs will be beneficial for product development.
© 2022 American Chemical Society.

Entities:  

Year:  2022        PMID: 35859872      PMCID: PMC9289999          DOI: 10.1021/acsmedchemlett.2c00145

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.632


  26 in total

Review 1.  Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

Authors:  R H Müller; K Mäder; S Gohla
Journal:  Eur J Pharm Biopharm       Date:  2000-07       Impact factor: 5.571

2.  Megastigmane, aliphatic alcohol and benzoxazinoid glycosides from Acanthus ebracteatus.

Authors:  T Kanchanapoom; R Kasai; C Picheansoonthon; K Yamasaki
Journal:  Phytochemistry       Date:  2001-11       Impact factor: 4.072

Review 3.  Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals.

Authors:  Mona H Aburahma; Shaimaa M Badr-Eldin
Journal:  Expert Opin Drug Deliv       Date:  2014-08-24       Impact factor: 6.648

4.  Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN).

Authors:  T Helgason; T S Awad; K Kristbergsson; D J McClements; J Weiss
Journal:  J Colloid Interface Sci       Date:  2009-03-28       Impact factor: 8.128

5.  Bioassay-guided isolation of anti-inflammatory, antinociceptive and wound healer glycosides from the flowers of Verbascum mucronatum Lam.

Authors:  Zeliha Akdemir; Ciğdem Kahraman; I Irem Tatlı; Esra Küpeli Akkol; Ipek Süntar; Hikmet Keles
Journal:  J Ethnopharmacol       Date:  2010-06-04       Impact factor: 4.360

6.  Encapsulation of Rifampicin in a solid lipid nanoparticulate system to limit its degradation and interaction with Isoniazid at acidic pH.

Authors:  Harinder Singh; Rohit Bhandari; Indu Pal Kaur
Journal:  Int J Pharm       Date:  2013-02-11       Impact factor: 5.875

7.  Anti-inflammatory phenylpropanoid glycosides from Clerodendron trichotomum leaves.

Authors:  Kyoung Hee Kim; Sungun Kim; Min Young Jung; In Hye Ham; Wan Kyunn Whang
Journal:  Arch Pharm Res       Date:  2009-01-29       Impact factor: 4.946

8.  An evaluation of the activity related to inflammation of four plants used in Thailand to treat arthritis.

Authors:  P Laupattarakasem; P J Houghton; J R S Hoult; A Itharat
Journal:  J Ethnopharmacol       Date:  2003-04       Impact factor: 4.360

9.  The anti-inflammatory and antioxidant activity of 25 plant species used traditionally to treat pain in southern African.

Authors:  Salmon A Adebayo; Jean P Dzoyem; Leshweni J Shai; Jacobus N Eloff
Journal:  BMC Complement Altern Med       Date:  2015-05-27       Impact factor: 3.659

10.  Development and evaluation of solid lipid nanoparticles of mometasone furoate for topical delivery.

Authors:  Jyotsana R Madan; Priyanka A Khude; Kamal Dua
Journal:  Int J Pharm Investig       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.